参考文献/References:
[1] Cornelis FH,Solomon SB.Treatment of primary liver tumors and liver metastases,part 2:non-nuclear medicine techniques[J].J Nucl Med,2018,59:1801-1808.
[2]Levillain H,Bagni O,Deroose CM,et al.International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres[J].Eur J Nucl Med Mol Imaging,2021,48:1570-1584.
[3]de Baere T,Ronot M,Chung JW,et al.Initiative on superselective conventional transarterial chemoembolization results(INSPIRE)[J].Cardiovasc Intervent Radiol,2022,45:1430-1440.
[4]张 雯,周永杰,颜志平.再论精细TACE[J].介入放射学杂志,2021,30:971-975.
[5]Taiji R,Lin EY,Lin YM,et al.Combined Angio-CT systems:a roadmap tool for precision therapy in interventional oncology[J].Radiol Imaging Cancer,2021,3:e210039.
[6]Lin EY,Jones AK,Chintalapani G,et al.Comparative analysis of intra-arterial cone-beam versus conventional computed tomography during hepatic arteriography for transarterial chemoembolization planning[J].Cardiovasc Intervent Radiol,2019,42:591-600.
[7]刘 浩,周菲菲,孙好凯,等.基于CBCT的三维重建技术用于TACE术治疗原发性肝癌患者对肿瘤供血动脉识别的价值[J].实用肝脏病杂志,2022,25:563-566.
[8]李桂芬,孙 毅,赵 妍,等.锥形束CT增强扫描在结直肠癌肝转移瘤TACE术中的指导作用[J].中西医结合肝病杂志,2022,32:443-446.
[9]Lucatelli P,De Rubeis G,Ginnani Corradini L,et al.Intra-procedural dual phase cone beam computed tomography has a better diagnostic accuracy over pre-procedural MRI and MDCT in detection and characterization of HCC in cirrhotic patients undergoing TACE procedure[J].Eur J Radiol,2020,124:108806.
[10]Schernthaner RE,Haroun RR,Duran R,et al.Improved visibility of metastatic disease in the liver during intra-arterial therapy using delayed arterial phasecone-beam CT[J].Cardiovasc Intervent Radiol,2016,39:1429-1437.
[11]孔铭新,于曰俊,马飞飞,等.锥形束CT双期扫描在肝恶性肿瘤介入治疗中的应用[J].介入放射学杂志,2019,28:38-41.
[12]Ozaki K,Kobayashi S,Matsui O,et al.Extrahepatic arteries originating from hepatic arteries:analysis using CT during hepatic arteriography and visualization on digital subtraction angiography[J].Cardiovasc Intervent Radiol,2017,40:822-830.
[13]刘建明,陈慧民,涂 亮,等.经桡动脉途径、CBCT三维血管重建辅助的精细TACE治疗原发性肝癌:附124例报道[J].中国普外基础与临床杂志,2022,29:570-575.
[14]Wang H,Han Y,Chen G,et al.Imaging biomarkers on Angio-CT for predicting the efficacy of transarterial chemoembo-lization in hepatocellular carcinoma[J].Quant Imaging Med Surg,2023,13:4077-4088.
[15]Letzen BS,Malpani R,Miszczuk M,et al.Lipiodol as an intra-procedural imaging biomarker for liver tumor response to transarterial chemoembolization:post-hoc analysis of a prospective clinical trial[J].Clin Imaging,2021,78:194-200.
[16]Tsai YC,Shih JH,Hwang HE,et al.Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization[J].Eur Radiol,2021,31:7464-7475.
[17]Taiji R,Lin YM,Chintalapani G,et al.A novel method for predicting hepatocellular carcinoma response to chemoembolization using an intraprocedural CT hepatic arteriography-based enhancement mapping:a proof-of-concept analysis[J].Eur Radiol Exp,2023,7:4.
[18]Kobe A,Zgraggen J,Messmer F,et al.Prediction of treatment response to transarterial radioembolization of liver metastases:radiomics analysis of pre-treatment cone-beam CT:a proof of concept study[J].Eur J Radiol Open,2021,8:100375.
[19]王 涛,姜文进,郑延波,等.C臂CT引导下经皮穿刺射频消融术治疗原发性肝癌的临床应用[J].医学影像学杂志,2020,30:1428-1432.
[20]Wijnen N,Bruijnen RCG,Vonken EJPA,et al.Conventional versus hepatic arteriography and C-arm CT-guided ablation of liver tumors(HepACAGA):a comparative analysis[J].Cancers(Basel),2024,16:1925.
[21]Yuan H,Liu F,Li X,et al.Angio-CT-Guided transarterial chemoembolization immediately in combination with radiofrequency ablation for large hepatocellular carcinoma[J].Acad Radiol,2019,26:224-231.
[22]Okusaka TKI,Okada SC,Ueno H,et al.Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features[J].Cancer,2002,95:1931-1937.
[23]Bannangkoon K,Hongsakul K,Tubtawee T,et al.Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization[J].Clin Mol Hepatol,2019,25:74-85.
[24]Watanabe Y,Ogawa M,Kaneko M,et al.Comparison of local recurrence in transcatheter arterial chemoembolization of hepatocellular carcinoma with or without accumulation of iodized oil beyond corona enhancement area:short-term results[J].Radiol Oncol,2021,56:69-75.
[25]Charoenvisal C,Tanaka T,Nishiofuku H,et al.Feasibility and techniques of securing 3D-safety margin in superselective transarterial chemoembolization to improve local tumor control for small hepatocellular carcinoma:an intend-to-treat analysis[J].Liver Cancer,2021,10:63-71.
[26]Angileri S,Lanza C,Carriero S,et al.Performance and safety of a reflux-control microcatheter used to perform DEB-TACE with LUMITM beads in HCC patients:preliminary experience[J].J Clin Med,2023,12:6630.
[27]Biondetti P,Lanza C,Carriero S,et al.Efficacy and safety of transarterial chemoembolization with DC beads LUMI in the treatment of HCC:experience from a tertiary centre[J].Technol Cancer Res Treat,2023,22:15330338231184840.
[28]Mikhail AS,Pritchard WF,Negussie AH,et al.Cone-beam computed tomography-based spatial prediction of drug dose after transarterial chemoembolization using radiopaque drug-eluting beads in woodchuck hepatocellular carcinoma[J].Invest Radiol,2022,57:495-501.
[29]Garin E,Tselikas L,Guiu B,et al.Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma(DOSISPHERE-01):a randomised,multicentre,open-label phase 2 trial[J].Lancet Gastroenterol Hepatol,2021,6:17-29.
[30]Kao YH,Hock Tan AE,Burgmans MC,et al.Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization[J].J Nucl Med,2012,53:559-566.
[31]Stein SI,Soliman MM,Sparapani J,et al.Conventional hepatic volumetry May Lead to inaccurate segmental yttrium-90 radiation dosimetry[J].Cardiovasc Intervent Radiol,2021,44:1973-1985.
[32]Rodríguez-Fraile M,Ezponda A,Grisanti F,et al.The joint use of(99 m)Tc-MAA-SPECT/CT and cone-beam CT optimizes radioembolization planning[J].EJNMMI Res,2021:23.
[33]Iwazawa J,Ohue S,Hashimoto N,et al.Comparison of the number of image acquisitions and procedural time required for transarterial chemoembolization of hepatocellular carcinoma with and without tumor-feeder detection software[J].Radiol Res Pract,2013,2013:580839.
[34]Bannangkoon K,Hongsakul K,Tubtawee T.Impact of cone-beam computed tomography with automated feeder detection software on the survival outcome of patients with hepatocellular carcinoma during treatment with conventional transarterial chemoembolization[J].BMC Gastroenterol,2021,21:419.
[35]Derbel H,Kobeiter H,Pizaine G,et al.Accuracy of a cone-beam CT virtual parenchymal perfusion algorithm for liver cancer targeting during intra-arterial therapy[J].J Vasc Interv Radiol,2018,29:254.e2-261.e2.
[36]Ridouani F,Ghosn M,Doustaly R,et al.Accuracy of a CBCT-based virtual injection software for vessel detection during hepatic arterial embolization[J].Eur J Radiol,2022,150:110273.
[37]Miyayama S,Yamashiro M,Nagai K,et al.Performance of novel virtual parenchymal perfusion software visualizing embolized areas of transcatheter arterial chemoembolization for hepatocellular carcinoma[J].Hepatol Res,2017,47:446-454.
[38]Derbel H,Krichen M,Chalaye JL,et al.Accuracy and reproducibility of a cone beam CT-based virtual parenchymal perfusion algorithm in the prediction of SPECT/CT anatomical and volumetric results during the planification of radioembolization for HCC[J].Eur Radiol,2023,33:3510-3520.
[39]Li Z,Jiao D,Si G,et al.Making timely remedial measures after TACE based on the results of cone-beam CT liver perfusion[J].Int J Hyperthermia,2021,38:428-436.
[40]Peisen F,Maurer M,Grosse U,et al.Intraprocedural cone-beam CT with parenchymal blood volume assessment for transarterial chemoembolization guidance:impact on the effectiveness of the individual TACE sessions compared to DSA guidance alone[J].Eur J Radiol,2021,140:109768.
[41]Pellerin O,Pereira H,Moussa N,et al.Can cone-beam CT tumor blood volume predicts the response to chemoembolization of colorectal liver metastases? Results of an observational study[J].Eur Radiol,2019,29:5022-5031.
[42]van den Hoven AF,Prince JF,de Keizer B,et al.Use of C-arm cone beam CT during hepatic radioembolization:protocol optimization for extrahepatic shunting and parenchymal enhancement[J].Cardiovasc Intervent Radiol,2016,39:64-73.
[43]Inoue A,Uemura R,Takaki K,et al.Clinical impact of low tube voltage computed tomography during hepatic arteriography with low Iodine to detect hepatocellular carcinoma before transarterial chemoembolization[J].Eur J Radiol,2022,154:110420.
[44]Scarfe WC,Farman AG.What is cone-beam CT and how does it work?[J].Dent Clin North Am,2008,52:707-730.
(收稿日期:2024-05-13)
(本文编辑:茹 实)
相似文献/References:
[1]左玉宽,刘作勤,唐军,等.血管内栓塞治疗颈动脉海绵窦瘘[J].介入放射学杂志,1999,(03):6.
[2]樊树峰,李政,顾伟中,等.经动脉导管热灌注体外模拟实验[J].介入放射学杂志,2006,(02):105.
FAN Shu-feng,LI Zheng,GU Wei-zhong,et al.Analog experiment of transarterial catheter hyperthermic infusion in vitro[J].J Intervent Med,2006,(05):105.
[3]董敏俊,范新东,石润杰.鼻咽血管纤维瘤术前双重介入栓塞的临床价值[J].介入放射学杂志,2006,(06):342.
DONG Min-jun,FAN Xin-dong,SHI Run-jie.Clinical value of pre-operative double embolization for nasopharyngeal angiofibroma[J].J Intervent Med,2006,(05):342.
[4]李建军,翟仁友,戴定可,等.急性大面积肺梗死的介入机械碎栓治疗[J].介入放射学杂志,2006,(06):336.
LI Jian-jun,ZHAI Ren-you,DAI Ding-ke,et al.Interventional mechanical thrombectomy procedure in treating acute massive pulmonary infarction [J].J Intervent Med,2006,(05):336.
[5]戴真煜,姚立正,李文会,等.经皮胆道支架联合支架旁125Ⅰ粒子条植入治疗恶性胆道梗阻[J].介入放射学杂志,2011,(09):706.
DAI Zhen-yu,YAO Li-zheng,LI Wen-hui,et al.Linear 125Ⅰ seeds strand implantation combined with biliary stenting for the treatment of malignant biliary obstruction[J].J Intervent Med,2011,(05):706.
[6]石建成 赵林 刘增品 刘怀军 王铁刚 周存和.经肱动脉颅内血管支架成形术二例[J].介入放射学杂志,2009,(02):120.
SHI Jian-cheng ZHAO Lin LIU Zeng-pin LIU Huai-jun WANG Tie-gang ZHOU Cun-he.Intracranial stent-plasty via brachial artery: a report of two cases[J].J Intervent Med,2009,(05):120.
[7]吴汉平,周汝明,梁惠明,等.介入病房的作用及管理体会[J].介入放射学杂志,1996,(03):164.
[8]申 刚,谭小云,陈德基,等.介入再通联合臭氧治疗阻塞性输卵管炎的实验研究[J].介入放射学杂志,2012,(05):405.
,,et al. Ｉｎｔｅｒｖｅｎｔｉｏｎａｌ ｆａｌｌｏｐｉａｎ ｔｕｂｅ ｒｅｃａｎａｌｉｚａｔｉｏｎ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ｏｚｏｎｅ ｉｎｊｅｃｔｉｏｎ ｉｎ ｔｒｅａｔｉｎｇ ｃｈｒｏｎｉｃ ｏｂｓｔｒｕｃｔｉｖｅ ｓａｌｐｉｎｇｉｔｉｓ： ａｎ ｅｘｐｅｒｉｍｅｎｔａｌ ｓｔｕｄｙ ｉｎ ｒａｂｂｉｔｓ[J].J Intervent Med,2012,(05):405.
[9]陈红宇,李琦,陈庆华,等.丹参酮ⅡＡ－聚乳酸／羟基乙酸微球对兔肝动脉栓塞作用的研究[J].介入放射学杂志,2010,(12):977.
CHEN Hong-yu,LI Qi,CHEN Qing-hua,et al.The embolization effect of tanshinoneⅡA-polylactic acid/glycolic acid microspheres on the hepatic artery in experimental rabbits[J].J Intervent Med,2010,(05):977.
[10]钟继明,李 浪,陆永光,等.经桡动脉冠心病介入诊疗中桡动脉痉挛的发生及其预测因素[J].介入放射学杂志,2011,(04):265.
ZHONG Ji-ming,LI Lang,LU Yong-guang,et al.Radial artery spasm occurred in transradial coronary intervention for coronary heart disease its occurrence and predictors[J].J Intervent Med,2011,(05):265.